Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jaromir Hubacek"'
Autor:
Martin Cernan, Tomas Szotkowski, Jaromir Hubacek, Milan Kolar, Edgar Faber, Karel Indrak, Tomas Papajik
Publikováno v:
Biomedical Papers, Vol 167, Iss 3, Pp 236-245 (2023)
Background. Infectious complications during induction chemotherapy of acute myeloid leukaemia are very common. Prophylactic use of antibiotics however is an ongoing challenge in this situation due to bacterial multi-drug resistance. The aim of this s
Externí odkaz:
https://doaj.org/article/3f4604fbe33c4c9797523bde05b76384
Autor:
Adam Kuba, Tomas Szotkowski, Peter Rohon, Edgar Faber, Peter Turcsanyi, Jaromir Hubacek, Milena Holzerova, Vojtech Prasil, Marie Jarosova, Karel Indrak
Publikováno v:
Biomedical Papers, Vol 159, Iss 2, Pp 294-298 (2015)
Background: Acute promyelocytic leukaemia (APL) is a subtype of acute myeloid leukaemia with high curability rates. However, it is often accompanied by severe coagulopathy and bleeding risk and thus represents a potentially fatal haematological emerg
Externí odkaz:
https://doaj.org/article/ea6b0196dc764f169dc3667274f75947
Autor:
Martin Cernan, Tomas Szotkowski, Jaromir Hubacek, Milan Kolar, Edgar Faber, Karel Indrak, Tomas Papajik
Publikováno v:
Biomedical Papers.
Infectious complications during induction chemotherapy of acute myeloid leukaemia are very common. Prophylactic use of antibiotics however is an ongoing challenge in this situation due to bacterial multi-drug resistance. The aim of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f48968b43af13fe6ca3b4b6baa41629
https://doi.org/10.5507/bp.2022.010
https://doi.org/10.5507/bp.2022.010